Medix Technology Recognized by 2021 Best in KLAS Software/Services Report
Organization receives high ratings for HIT Staffing and HIT Implementation Leadership CHICAGO--(BUSINESS WIRE)--Medix Technology, a division of Medix providing expert...
Month: February 2021
Rithem Life Sciences Announces Formation of Board of Directors
WILMINGTON, Del.--(BUSINESS WIRE)--Rithem Life Sciences, a Wilmington, Delaware-based medical device company and developer of safe and efficacious life-saving portable products,...
MatrixCare Home Health EHR Solution Wins Best in KLAS – Again
BLOOMINGTON, Minn.--(BUSINESS WIRE)--#healthIT--MatrixCare announced today its Home Health and Hospice EHR solution has won Best in KLAS for Home Health...
Nanit Transforms the Crib, Using AI to Track Baby’s Height and Growth with Smart Sheets
NEW YORK, Feb. 2, 2021 /PRNewswire/ -- Nanit, creators of the most advanced baby monitor, is once again modernizing the connected...
Planet 13 Announces Closing of C$69 Million Bought Deal Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LAS VEGAS, NV /...
Avinger Closes $14.4 Million Bought Deal Offering of Common Stock
REDWOOD CITY, CA / ACCESSWIRE / February 2, 2021 / Avinger, Inc. (NASDAQ:AVGR) (the "Company"), a commercial-stage medical device company...
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033
MONTREAL, QC / ACCESSWIRE / February 2, 2021 / Sunshine Biopharma Inc. (OTC PINK:SBFM), a pharmaceutical company focused on the...
CEVEC and CARISMA Therapeutics Sign License Agreement for the Use of CAP(R) Technology in Anti-Tumor Cell Therapies
CARISMA receives full rights to use the CAP(R) Technology for the production of adenoviral vectors across their whole portfolio of...
Viveve Announces Expansion of IP Portfolio with Issuance of S. Korean Patent
ENGLEWOOD, CO / ACCESSWIRE / February 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's...
CureVac Announces Closing of $450 million Follow-on Public Offering of Common Shares
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / February 2, 2021 / CureVac N.V. (Nasdaq:CVAC) ("CureVac" or the "Company"), a...
Tauriga Sciences Inc. Expands Its International Presence Through Opening of Tauri-Gum Store on the Jumia Online Marketplace Platform
NEW YORK, NY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a...
Allied Completes Acquisition of Pacific Sun Fungi: A Leader in the Psilocybin Space
KELOWNA, British Columbia, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTCQB: ALID) – an international medical company focused...
PaxMedica Receives FDA Orphan Drug Designation for Use of PAX-101 (IV suramin) in a Rare Tropical Disease
Company Pursuing Development of PAX-101 as Treatment for Autism Spectrum Disorder and Other Neurodevelopmental Conditions WOODCLIFF LAKE, N.J., Feb. 02,...
EncrypGen Offers Individuals A Safer Path To Scaling Up The DNA Data Marketplace
New York, New York, Feb. 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EncrypGen, the world’s first blockchain-mediated genomic DNA...
BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder
Vancouver, Feb. 02, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...
BioCardia Update on Cell Therapy Product Development and 2021 Milestones
SAN CARLOS, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. a leader in the development of comprehensive solutions for...
Pluristem Therapeutics Inc. Announces $30 Million Registered Direct Offering
HAIFA, Israel, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a...
NeurMedix Obtains FDA Authorization for Pivotal Phase 3 Alzheimer’s Trial
NeurMedix Expects to Enroll the First Patient in May 2021SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- NeurMedix, LLC, a...
Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study
- Patients’ Cognition Improved 1.6 Points on ADAS-Cog11 -- Patients’ Behavior Improved 1.3 Points on NPI - - Improvements Maintained...
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
REDWOOD CITY, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- A day after announcing their new immuno-oncology collaboration, Coherus BioSciences, Inc. (Nasdaq:...